[go: up one dir, main page]

AU2001278375A1 - Composition for pharmaceutical and cosmetic products - Google Patents

Composition for pharmaceutical and cosmetic products

Info

Publication number
AU2001278375A1
AU2001278375A1 AU2001278375A AU7837501A AU2001278375A1 AU 2001278375 A1 AU2001278375 A1 AU 2001278375A1 AU 2001278375 A AU2001278375 A AU 2001278375A AU 7837501 A AU7837501 A AU 7837501A AU 2001278375 A1 AU2001278375 A1 AU 2001278375A1
Authority
AU
Australia
Prior art keywords
composition
cosmetic products
pharmaceutical
spirulina
wounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001278375A
Inventor
Hartmut Kobilke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2000133939 external-priority patent/DE10033939A1/en
Priority claimed from DE20015177U external-priority patent/DE20015177U1/en
Application filed by Individual filed Critical Individual
Publication of AU2001278375A1 publication Critical patent/AU2001278375A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Abstract of Disclosure A composition for pharmaceutical products and cosmetic products contains IgY egg yolk antibodies of SPF hens and microalgae extracts from Spirulina species, Spirulina varieties, and Chlorella species. The composition can also contain oxytetracycline and preservatives or antioxidants. The composition prepared as a salve is used for healing infected wounds and for preventing the infection of wounds.
AU2001278375A 2000-07-05 2001-07-05 Composition for pharmaceutical and cosmetic products Abandoned AU2001278375A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE2000133939 DE10033939A1 (en) 2000-07-05 2000-07-05 Composition containing egg yolk antibodies and optionally microalgae extracts and oxytetracycline, useful for treatment of inflammatory conditions, especially wounds
DE10033939.5 2000-07-05
DE20015177U DE20015177U1 (en) 2000-09-02 2000-09-02 Composition for pharmaceuticals and cosmetics
DE20015177.0 2000-09-02
PCT/DE2001/002589 WO2002002642A2 (en) 2000-07-05 2001-07-05 Composition for pharmaceutical and cosmetic products

Publications (1)

Publication Number Publication Date
AU2001278375A1 true AU2001278375A1 (en) 2002-01-14

Family

ID=26006366

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001278375A Abandoned AU2001278375A1 (en) 2000-07-05 2001-07-05 Composition for pharmaceutical and cosmetic products

Country Status (6)

Country Link
US (1) US20030091560A1 (en)
EP (1) EP1299420B1 (en)
AT (1) ATE386056T1 (en)
AU (1) AU2001278375A1 (en)
DE (1) DE50113598D1 (en)
WO (1) WO2002002642A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014074770A2 (en) 2012-11-09 2014-05-15 Heliae Development, Llc Balanced mixotrophy methods
WO2014074772A1 (en) 2012-11-09 2014-05-15 Heliae Development, Llc Mixotrophic, phototrophic, and heterotrophic combination methods and systems
MA40847A (en) * 2014-10-22 2017-09-13 Raffaele Migliaccio COMBINATION CONSISTING OF SPIRULIN AND PALMITOYLETHANOLAMIDE AND / OR PHARMACEUTICALLY ACCEPTABLE SALTS OR DERIVATIVES OF THESE AND THEIR FORMULATIONS, FOR USE IN THE PREVENTION AND / OR TREATMENT OF CONDITIONS OF TISSUE HYPERACTIVITY
AR103173A1 (en) 2014-12-22 2017-04-19 Novarits Ag PHARMACEUTICAL PRODUCTS AND STABLE LIQUID COMPOSITIONS OF ANTIBODIES IL-17
CN105688210A (en) * 2016-03-10 2016-06-22 陕西瑞凯生物科技有限公司 Yolk biological protein skin repair dressing and preparation method thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5279M (en) * 1964-04-08 1967-09-11
US4011313A (en) * 1974-06-07 1977-03-08 Syntex (U.S.A.) Inc. Medicament preparations
SU812291A1 (en) * 1979-05-28 1981-03-15 Институт Микробиологии Ан Узбекскойсср Method of obtaining lipides
HU200103B (en) * 1987-04-01 1990-04-28 Biogal Gyogyszergyar Process for producing pharmaceutical compositions for treating lack of epithelium
JP2953529B2 (en) * 1990-05-25 1999-09-27 寶酒造株式会社 New cosmetics
JP3257905B2 (en) * 1994-07-29 2002-02-18 一丸ファルコス株式会社 Skin sticking sheet
US5709855A (en) * 1995-09-22 1998-01-20 Bockow; Barry I. Compositions of spirulina algae and omega fatty acids for treatment of inflammation and pain
WO1997037636A1 (en) * 1996-04-03 1997-10-16 Elias Hakalehto Therapeutic and preventive method against harmful microbes
FR2747922B1 (en) * 1996-04-26 1999-02-12 Codif International Sa USE OF NATURAL EXTRACTS OF ALGAE TO DEVELOP A PRODUCT FOR PREVENTING AND TREATING SKIN DISEASES
IE970541A1 (en) * 1997-07-25 1999-01-27 Michael Anthony Folan Maternal immune secretions and their use in the treatment and/or prophylaxis of the buccal cavity
IT1297080B1 (en) * 1997-11-26 1999-08-03 Andrea Carnevali COMPOSITION FOR THE TREATMENT OF BURNS, SOLAR erythema, ABRASIONS, SAGS AND SKIN IRRITATIONS
CO5150202A1 (en) * 1998-12-31 2002-04-29 Kimberly Clark Co COMPOSITION OF FACIAL TISSU AND METHOD FOR USE FOR THE SECRETARY OF SKIN IRRITANTS OF THE NASAL SECRETION
DE29904221U1 (en) * 1999-02-26 1999-06-10 Heiß, Rosemarie, VR Dr.med.vet., 15370 Fredersdorf Specific IgY egg yolk antibodies to be obtained permanently
DE20012123U1 (en) * 2000-07-05 2001-01-11 Kobilke, Hartmut, Dr.med.vet., 14797 Damsdorf Medicinal and wound ointment

Also Published As

Publication number Publication date
ATE386056T1 (en) 2008-03-15
WO2002002642B1 (en) 2002-07-25
WO2002002642A3 (en) 2002-04-18
EP1299420B1 (en) 2008-02-13
EP1299420A2 (en) 2003-04-09
WO2002002642A2 (en) 2002-01-10
DE50113598D1 (en) 2008-03-27
US20030091560A1 (en) 2003-05-15

Similar Documents

Publication Publication Date Title
AU553185B2 (en) Process for the preparation of polysaccharide-protein complexes from bacterial capsules, obtained products and immunogenic compositions containing them
AU3126097A (en) Collagen binding protein compositions and methods of use
ATE243030T1 (en) ORAL PREPARATION FOR PROPHYLACTIC/THERAPEUTIC TREATMENT OF HELICOBACTOR SP. INFECTIONS
SE9704693D0 (en) Method of the prophylactic treatment of mastitis
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
NO20004282D0 (en) Matrix protein preparations for wound healing
ATE208630T1 (en) IMMUNOTHERAPY MEDICINAL PRODUCTS CONTAINING ANTIBODIES THAT SPECIFICALLY RECOGNIZE THE MHCII ANTIGEN OF A PATIENT TO BE TREATED
MY117323A (en) Method of scavenging free radicals using orange extract
AU2001278375A1 (en) Composition for pharmaceutical and cosmetic products
WO1997005899A3 (en) Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
AU2030497A (en) Propynyl or dienyl biaromatic compounds
BR9811548A (en) Immune maternal secretions and their use in the treatment and / or prophylaxis of human body conditions
WO2003009859A1 (en) Immunotherapy for humans
IT8720389A0 (en) RETINO ESTERS OF ANTIBIOTICS, THEIR PREPARATION PROCEDURE AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS THAT CONTAIN THEM.
AU5643299A (en) Humic acid and its use in the treatment of various conditions
CA2037779A1 (en) Antibiotic ge 2270 factors b1, b2, c1, c2, d1, d2, e and t
NO20011667D0 (en) Treatment of dyspepsia
AU591017B2 (en) Human monoclonal antibody and drug for prophylaxis and treatment of infectious diseases comprising same as effective ingredient
JPS57143000A (en) Antibiotic compound, manufacture and medical use
AU5848690A (en) Preparation for topical treatment of infections caused by virus, bacteria and fungi
RU94041768A (en) Agent for alcoholic dependence treatment
NO904611L (en) PHARMACEUTICAL PREPARATIONS CONTAINING DEOXYRIBONUCLEOSIDES FOR SPECIAL HEALTH.
UA28283A (en) Natural drug
GR1002969B (en) Medicinal preparation based on fetal cell suspension, having immune substituting effect and method of treatment of acquired immune deficiency syndrome (HIV infection) with the use of said preparation.